|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
���������� |
|
ݡ���� |
|
����ϸ�� |
|
T�ܰ�ϸ�� |
| ��������������� | |
|
�ƻ� |
|
��� |
|
֣־�� |
| PubMed | |
|
Article by TANG Hui |
|
Article by XU Jin-hua |
|
Article by ZHENG Zhi-zhong |
CC����������������ݡ����
�ƻ�, ���, ֣־��
������ѧ������ɽҽԺƤ����, �Ϻ�200040
CC������������������ϸ����T�ܰ�ϸ������֢ϸ����ѡ����������,���̬��Ӧ������ء�����ݡ������һ�ֳ����ı�̬��Ӧ��Ƥ����,�䷢�����Ƴ��ˢ��ͱ�̬��Ӧ���ٷ���֮��,���漰����������ϸ������Ϊ�����ijٷ��ࡣCC�����������ڳٷ����̬��Ӧ�ķ�������չ������������Ҫ�����á�
CC Chemokines and Chronic Urticaria
Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China
Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China
CC chemokines are selective chemoattractants for eosinophils and T lymphocytes, and closely related to allergic reaction. Chronic urticaria is a common allergic skin disease. In addition to the early-phase allergic reactions of type I, the late-phase allergic reactions characterized by the infiltration of eosinophils are involved in the pathogenesis of chronic urticaria. CC chemokines play an important role in the occurrence and development of late-phase allergic reactions in chronic urticaria.
[2] Miyamasu M,Yamaguchi M,Nakajima T,et al.Th1-derived cytokine IFN-gamma is a potent inhibitor of eotaxin synthesis in vitro.Int Immunol,1999,11:1001-1004.
[3] Togawa M,Kiniwa M,Nagai H.The roles of IL-4,IL-5 and mast cells in the accumulation of eosinophils during allergic cutaneous late phase reaction in mice.Life Sci,2001,69:699-705.
[4] Caproni M,Volpi W,Macchia D,et al.Infiltrating cells and related cytokines in lesional skin of patients with chronic idiopathic urticaria and positive autologous serum skin test.Exp Dermatol,2003,12:621-628.
[5] Piconi S,Trabattoni D,Iemoli E,et al.Immune profiles of patients with chronic idiopathic urticaria.Int Arch Allergy Immunol,2002,128:59-66.
[6] Zweiman B,Kaplan AP,Tong L,et al.Cytokine levels and inflammatory responses in developing late-phase allergic reactions in the skin.J Allergy Clin Immunol,1997,100:104-109.
[7] Beck LA,Dalke S,Leiferman KM,et al.Cutaneous injection of RANTES causes eosinophil recruitment:comparison of nonallergic and allergic human subjects.J Immunol,1997,159:2962-2972.
[8] Ying S,Robinson DS,Meng Q,et al.C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects:association of eotaxin with early 6-hour eosinophils,and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia,and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).J Immunol,1999,163:3976-3984.
[9] Menzies-Gow A,Ying S,Sabroe I,et al.Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils,basophils,neutrophils,and macrophages as well as features of early-and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers.J Immunol,2002,169:2712-2718.
[10] Menzies-Gow A,Ying S,Phipps S,et al.Interactions between eotaxin,histamine and mast cells in early microvascular events associated with eosinophil recruitment to the site of allergic skin reactions in humans.Clin Exp Allergy,2004,34:1276-1282.
[11] Borchers MT,Ansay T,DeSalle R,et al.In vitro assessment of chemokine receptor-ligand interactions mediating mouse eosinophil migration.J Leukoc Biol,2002,71:1033-1041.
[12] Powell WS,Ahmed S,Gravel S,et al.Eotaxin and RANTES enhance 5-oxo-6,8,11,14-eicosatetraenoic acid-induced eosinophil chemotaxis.J Allergy Clin Immunol,2001,107:272-278.
[13] Yamamoto H,Nagata M,Sakamoto Y.CC chemokines and transmigration of eosinophils in the presence of vascular cell adhesion molecule 1.Ann Allergy Asthma Immunol,2005,94:292-300.
[14] Ferrer M,Luquin E,Sanchez-Ibarrola A,et al.Secretion of cytokines,histamine and leukotrienes in chronic urticaria.Int Arch Allergy Immunol,2002,129:254-260.
[15] Reale M,Barbacane RC,DiGioacchino M,et al.Differential expression and secretion of RANTES and MCP-1 in activated peripheral blood mononuclear cell cultures of atopic subjects.Immunol Lett,2001,76:7-14.
[16] Banwell ME,Tolley NS,Williams TJ,et al.Regulation of human eotaxin-3/CCL26 expression:modulation by cytokines and glucocorticoids.Cytokine,2002,17:317-323.
[17] Fahy O,Porte H,Senechal S,et al.Chemokine-induced cutaneous inflammatory cell infiltration in a model of Hu-PBMC-SCID mice grafted with human skin.Am J Pathol,2001,158:1053-1063.
[18] Sebastiani S,Allavena P,Albanesi C,et al.Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.J Immunol,2001,166:996-1002.
[19] Jinquan T,Quan S,Feili G,et al.Eotaxin activates T cells to chemotaxis and adhesion only ifinduced to express CCR3 by IL-2 together with IL-4.J Immunol,1999,162:4285-4292.
[20] Suzuki K,Morokata T,Morihira K,et al.In vitro and in vivo characterization of a novel CCR3 antagonist,YM-344031.Biochem Biophys Res Commun,2006,339:1217-1223.